Non‑blood management of severe anaemia in pregnant human immunodeficiency virus positive Jehovah’s Witness patients in the University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria
Main Article Content
Abstract
Background: Blood transfusion is clinically used to treat severe anaemia, but some people refuse it for its adverse effects and religious reasons.
Aim: To present two Jehovah's Witness pregnant human immunodeficiency virus (HIV) positive women who were managed successfully without blood at the University of Port Harcourt Teaching Hospital.
Methods: Case series - The first case, a 27-year-old Jehovah's Witness woman was found to be retropositive with severe anaemia. She had a packed cell volume (PCV) of 14% in her second trimester in pregnancy. She was treated with oral haematinics, and the PCV rose to 34% before an elective caesarean section. The second case was a 29-year-old Jehovah's Witness woman who was admitted for chronic cough and fever in her second trimester. On further investigation, she was found to have pulmonary tuberculosis, septicaemia and severe anaemia with a PCV of 17%. She declined blood transfusion and was managed with parenteral iron and erythropoietin. Both cases had safe deliveries with good fetomaternal outcome.
Conclusion: Pregnant patients who decline blood transfusion can be adequately managed if they register in the first trimester or the early second trimester and such cases need good team management and cooperation between the patient and the teams for a good outcome.
Downloads
Article Details
The journal grants the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License.
References
1. Currie J, Hogg M, Patel N, Madgwick K, Yoong W. Management of women who decline blood and blood products in pregnancy. Obstet
Gynaecol 2010;12:13‑20.
2. Narita T, Hamano I, Kusaka A, Murasawa H, Tokui N, Imanishi K, et al. Surgery without blood transfusion for giant paraganglioma in a
Jehovah’s Witness patient. Case Rep Oncol 2014;7:233‑8.
3. Thomas JM. Alternative non‑blood management in obstetrics and gynaecology (letter). J Obstet Gynecol Can 1993;15:1042‑3.
4. World Health Organization. The Clinical Use of Blood: Handbook. Geneva: WHO, 2003; 122‑3.
5. Adadevoh SW. The pregnant patients. In: Parry EH, editor. Principles and Practice of Medicine in Africa. 2nd ed. Ibadan: Oxford Medical Publications, 1984; 992‑1006.
6. Idowu OA, Mafiana CF, Dapo S. Anaemia in pregnancy: A survey of pregnant women in Abeokuta, Nigeria. Afr Health Sci 2005;5:295‑9.
7. Hoffbrand AV, Moss PA, editors. Hypochromic anaemias. In: Hoffbrand’s Essential Haematology. 7th ed. London: Wiley Blackwell
Publishers, 2015; 27‑40.
8. Migden DR, Braen GR. The Jehovah’s Witness blood refusal card: Ethical and medicolegal considerations for emergency physicians.
Acad Emerg Med 1998;5:815‑24.
9. Auerbach M, Goodnough LT, Picard D, Maniatis A. The role of intravenous iron in anemia management and transfusion avoidance.
Transfusion 2008;48:988‑1000.
10. Koenig HM, Levine EA, Resnick DJ, Meyer WJ. Use of recombinant human erythropoietin in a Jehovah’s Witness. J Clin Anesth
1993;5:244‑7.
11. Muirhead N, Bargman J, Burgess E, Jindal KK, Levin A, Nolin L, et al. Evidence‑based recommendations for the clinical
use of recombinant human erythropoietin. Am J Kidney Dis 1995;26(2 Suppl 1):S1‑24.
12. Ifudu O. Patient characteristics determining rHuEPO dose requirements. Nephrol Dial Transplant 2002;17(Suppl 5):38‑41